Untitled Document
www.expresspharmaonline.com FORTNIGHTLY INSIGHT FOR PHARMA PROFESSIONALS
1-15 June, 2008  
Untitled Document
Sections

Go Gujarat!
Market
Management
Research
Pharma Life

Services
Open Forum
Appointments
Subscribe/Renew
Archives
Editorial Calendar
Media Kit
Contact Us
Network Sites
Express Computer
CIO Decisions
Express Channel Business
Express Hospitality
Express TravelWorld
feBusiness Traveller
Exp. Healthcare Mgmt.
Express Textile
Group Sites
ExpressIndia
Indian Express
Financial Express




    RESEARCH - Expertise for Drug Development
 

Ousting the hepatitis-B bug
It has been 19 years since the first time hepatitis-B virus was detected. Fast forwarding to the current year, the virus still refuses to be cleard. Aashruti Kak finds out why

RT-PCR sets new trends in medical research
The real time Polymerase Chain Reaction (PCR) is faster, less laborious, highly sensitive and specific compared to PCR, and has wide applications

Piramal Life Sciences initiates phase I trials
Piramal Life Sciences, commenced a phase I study of a new, orally active glucose-lowering compound, P1736, in Netherlands. P1736 is a non-PPAR compound and is being developed for the treatment of type II diabetes.


Untitled Document
Untitled Document
© Copyright 2001: Indian Express Newspapers (Mumbai) Limited (Mumbai, India). All rights reserved throughout the world. This entire site is compiled in Mumbai by the Business Publications Division (BPD) of the Indian Express Newspapers (Mumbai) Limited. Site managed by BPD.